Latest / Matt Brown Show - Conversations That Power The Business World.
MBS524 - Creating the next wave of cancer therapeutics - Charles Theuer, CEO TraconPharma.com (Built in California #33)
Send us Fan Mail
TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, Our lead product candidate, envafolimab, is a PD-L1 antibody that is being developed for the treatment of sarcoma. Our other product candidates are YH001, a CTLA-4 antibody that is in Phase 1/2 development for the treatment of sarcoma, TRC102, a small molecule that is in Phase 2 clinical development for the treatment of mesothelioma; TJ004309, a CD73 antibody that is in Phase 1 testing, that is being developed…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.